Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 33 recruiting now full pipeline

Congenital Heart Disease: full-pipeline trial registry

33 of 64 indexed Congenital Heart Disease trials are currently recruiting.

Corpus placement: #215 of 28,707 conditions by registered trial count.

64 US clinical trials · 33 currently recruiting · #215 of 28,707 conditions by registered trial count

Congenital Heart Disease: 64 US clinical trials tracked, 33 recruiting.

Congenital Heart Disease is the subject of 64 registered US clinical trials on ClinicalTrials.gov, 33 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Boston Children's Hospital, running 9 of these trials.

Enrollment posture brief

Registry condition congenital-heart-disease

OPEN 33 | RECR 52% | LATE 3 | EARLY 4 | RANK #215 | SPON 9

Nearest open-share peer: Cutaneous Melanoma (52% recruiting · 31 trials)

Anatomic Stage I Breast Canc54.7%Congenital Heart Disease (th…52%Pulmonary Arterial Hypertens32.8%Non-Hodgkin's Lymphoma18.8%Diabetic Macular Edema15.6%
Open-enrollment share among volume-matched conditions near Congenital Heart Disease

Congenital Heart Disease lists 33 open slots (52% of 64 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Congenital Heart Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Congenital Heart Disease is recruiting above its size-band peers.

    33 of 64 indexed trials (51.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Congenital Heart Disease trials is spread across many organizations.

    Boston Children's Hospital accounts for 9 of 64 trials (14.1%). 42 distinct sponsors appear on at least one study for this condition label.

  3. Typical Congenital Heart Disease enrolment sits around 92 participants.

    Median target enrolment is 92 among the 64 trials that report a genuine target (sentinel values excluded). 33 of those (51.6%) plan for fewer than 100 participants.

  4. Congenital Heart Disease splits between interventional and observational designs.

    34 interventional and 30 observational studies make up this index (53.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 21Phase 33

Open and recent trials

64 total, page 1 of 2

RECRUITING 1,000 participants

Genetics of Congenital Heart Disease

Nationwide Children's Hospital

NCT01192048

RECRUITING NA 1,000 participants

Improving Congenital Heart Disease Care

University of California, San Francisco

NCT06581484

RECRUITING 1,000 participants

Development of CIRC Technologies

The Cleveland Clinic

NCT05654272

RECRUITING 600 participants

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Emory University

NCT00243776

RECRUITING 500 participants

The Co-Op @ HeartWorks

HeartWorks

NCT06469918

RECRUITING 400 participants

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Leiden University Medical Center

NCT06932081

RECRUITING 300 participants

ATrial Tachycardia PAcing Therapy in Congenital Heart

Ian Law

NCT03209583

RECRUITING 300 participants

IPSC Repository of Pediatric Cardiovascular Disease

Mingtao Zhao

NCT05550324

RECRUITING 300 participants

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

Mayo Clinic

NCT05122962

RECRUITING NA 225 participants

The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults

Boston Children's Hospital

NCT05258981

RECRUITING NA 200 participants

Fontan Fitness Trial

Children's Hospital of Philadelphia

NCT06918795

RECRUITING NA 200 participants

The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study

Scripps Translational Science Institute

NCT06244940

RECRUITING NA 200 participants

A Study of Hemodynamic Cardiopulmonary Exercise for CHD

Mayo Clinic

NCT06566196

RECRUITING 200 participants

Effect of Fetal Aortic Valvuloplasty on Outcomes

Queen Silvia Children's Hospital, Gothenburg, Sweden

NCT05386173

RECRUITING NA 200 participants

HFNC vs NIPPV Following Extubation

Emory University

NCT05869825

RECRUITING NA 150 participants

Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery

Augusta University

NCT05881564

RECRUITING 100 participants

Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT05213598

RECRUITING NA 100 participants

Ventripoint Single Ventricle Study

Duke University

NCT05262907

RECRUITING 100 participants

Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac Surgery

Boston Children's Hospital

NCT04299828

RECRUITING 92 participants

Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

Icahn School of Medicine at Mount Sinai

NCT06575270

RECRUITING 50 participants

A Study of Invasive Hemodynamic for MACHD Registry

Mayo Clinic

NCT05849025

RECRUITING 50 participants

Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables

The Cleveland Clinic

NCT06818760

RECRUITING 50 participants

Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease

Boston Children's Hospital

NCT05241418

RECRUITING Phase 2 50 participants

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Stanford University

NCT06080074

RECRUITING Phase 1 50 participants

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

HeartWorks

NCT05647213

RECRUITING Phase 1 50 participants

Propranolol Treatment for Postoperative Chylothorax

June Wu

NCT06833320

RECRUITING 45 participants

PDA for Kidneys Study

University of Wisconsin, Madison

NCT06658496

RECRUITING Phase 3 45 participants

Effect of Sacubitril-Valsartan on Cardiac Structure and Function

Mayo Clinic

NCT06693674

RECRUITING NA 40 participants

Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents

Children's Hospital Los Angeles

NCT07023367

RECRUITING NA 36 participants

Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment

Columbia University

NCT03891160

RECRUITING NA 35 participants

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Starlight Cardiovascular

NCT07114718

RECRUITING 30 participants

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Medical College of Wisconsin

NCT03775954

RECRUITING 10 participants

Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis

Boston Children's Hospital

NCT06434207

ACTIVE NOT RECRUITING 5,000 participants

Technical Development for Pediatric Cardiovascular MRI

Children's National Research Institute

NCT02892136

ACTIVE NOT RECRUITING 330 participants

Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery in Children

Boston Children's Hospital

NCT05687292

ACTIVE NOT RECRUITING NA 150 participants

Harmony TPV Post-Approval Study

Medtronic Cardiovascular

NCT05077774

ACTIVE NOT RECRUITING Phase 3 144 participants

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Carelon Research

NCT04702373

ACTIVE NOT RECRUITING NA 135 participants

Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making

University of Utah

NCT04437069

ACTIVE NOT RECRUITING NA 86 participants

The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study

Medtronic Heart Valves

NCT02979587

ACTIVE NOT RECRUITING NA 86 participants

ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

Edwards Lifesciences

NCT03130777

ACTIVE NOT RECRUITING NA 51 participants

Autus Valve Pivotal Study

Autus Valve Technologies

NCT05006404

ACTIVE NOT RECRUITING NA 36 participants

Pediatric Adhesion and New Dermal Approach Study

iRhythm Technologies

NCT07118124

ACTIVE NOT RECRUITING NA 33 participants

Peer Coaching Intervention in Young Adults With Congenital Heart Disease

Duke University

NCT04271358

COMPLETED 8,415 participants

Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II

KU Leuven

NCT04902768

COMPLETED 6,147 participants

The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease

Pediatrix

NCT01749059

COMPLETED 273 participants

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Carelon Research

NCT05312177

COMPLETED NA 218 participants

Transitional Telehealth Home Care: REACH

Children's Hospital of Philadelphia

NCT01941667

COMPLETED 200 participants

Transverse Thoracic Plane Block in the Pediatric Cardiac Patient

Ochsner Health System

NCT04138745

COMPLETED NA 180 participants

Evaluation of Web-based Transition Education to Enhance Transition Readiness

University of Michigan

NCT03303248

COMPLETED 146 participants

Clinical Characteristics and Associations of the "Good Fontan" Patient

Boston Children's Hospital

NCT03470428

Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 3 3

Named interventions

Most-linked intervention names on Congenital Heart Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Harmony TPV System Device
2 trials
MRI Diagnostic test
2 trials
Web-based Educational Intervention Behavioral
1 trials
This is an observational study, there is no intervention Other
1 trials
MyHeartBaby Program Behavioral
1 trials
Near-infrared spectroscopy (NIRS) Procedure
1 trials
No ACE Inhibitor Other
1 trials
Angiotensin Converting Enzyme Inhibitor Drug
1 trials

US sites by state

Facility locations filed on Congenital Heart Disease trials. A trial with sites in several states counts in each.

Massachusetts 16 trials
Ohio 15 trials
California 14 trials
New York 11 trials
Georgia 10 trials
Pennsylvania 9 trials
Minnesota 9 trials
Utah 8 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Congenital Heart Disease page

64 registered trials, 33 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Congenital Heart Disease condition card totals 64 registered trials; most-linked intervention Harmony TPV System; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.